Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
Work
Year: 2012
Type: article
Abstract: Programmed death 1 (PD-1) protein, a T-cell coinhibitory receptor, and one of its ligands, PD-L1, play a pivotal role in the ability of tumor cells to evade the host's immune system. Blockade of inter... more
Source: New England Journal of Medicine
Authors Julie R. Brahmer, Scott S. Tykodi, Laura Q.M. Chow, Wen-Jen Hwu, Suzanne L. Topalian +21 more
Institutions Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Cancer Research Center, Seattle Cancer Care Alliance, Fred Hutch Cancer Center +9 more
Cites: 39
Cited by: 7,436
Related to: 10
FWCI: 316.9
Citation percentile (by year/subfield): 100
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: bronze